TFRC and cholangiocarcinoma: In general, we found a new effect of NUF2 on the proliferation and metastasis of CCA cells, revealing how NUF2-TFR1 interaction impacted the stability of TFR1 to activate p38/MAPK signaling, which can work as an ideal therapeutic target in future.